Search research articles
Contact Us
Filters
Showing results (1-10 of 185) with videos related to
Page
of 19
Sort By:
Drug Design, Development and Therapy
|
August 15, 2015
The role of taxanes in triple-negative breast cancer: literature review
Giorgio Mustacchi, Michelino De Laurentiis
Recenti Progressi in Medicina
|
January 8, 2020
[Clinical applications of trastuzumab in the management of HER-2-positive breast cancer.]
Lucia Del Mastro, Michelino De Laurentiis
Future Oncology (London, England)
|
May 9, 2017
Eribulin as an effective monotherapy in a chemo-pretreated woman with metastatic breast cancer: a case report
Roberta Caputo, Daniela Cianniello, Michelino De Laurentiis
Cancers
|
April 23, 2022
Male Breast Cancer: From Molecular Genetics to Clinical Management
Matilde Pensabene, Claudia Von Arx, Michelino De Laurentiis
Oncology and Therapy
|
May 31, 2021
How to Optimise Extended Adjuvant Treatment with Neratinib for Patients with Early HER2+ Breast Cancer
Michael Untch, Miguel Martin, Michelino De Laurentiis, et al.
Frontiers in Oncology
|
August 21, 2023
Long-term complete response with third-line PARP inhibitor after immunotherapy in a patient with triple-negative breast cancer: a case report
Roberta Caputo, Martina Pagliuca, Matilde Pensabene, et al.
Frontiers in Oncology
|
February 9, 2026
Direct pulmonary delivery route in lung cancer: a highway for siRNA therapeutics
Muhammad Shakeeb Sharif, Luca Luzzi, Michelino De Laurentiis, et al.
Cancers
|
May 14, 2020
Long Non-Coding RNA <i>HOTAIR</i> in Breast Cancer Therapy
Monica Cantile, Maurizio Di Bonito, Margherita Cerrone, et al.
Oncotarget
|
April 14, 2017
A meta-analytic review of the relationship of cancer coping self-efficacy with distress and quality of life
Andrea Chirico, Fabio Lucidi, Thomas Merluzzi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 5, 2022
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
Vincenzo Adamo, Lorenzo Antonuzzo, Marco Danova, et al.
Page
of 19
Search research articles
Search
Showing results (1-10 of 185) with videos related to
Sort By:
Page
of 19
Drug Design, Development and Therapy
|
August 15, 2015
The role of taxanes in triple-negative breast cancer: literature review
Giorgio Mustacchi, Michelino De Laurentiis
Recenti Progressi in Medicina
|
January 8, 2020
[Clinical applications of trastuzumab in the management of HER-2-positive breast cancer.]
Lucia Del Mastro, Michelino De Laurentiis
Future Oncology (London, England)
|
May 9, 2017
Eribulin as an effective monotherapy in a chemo-pretreated woman with metastatic breast cancer: a case report
Roberta Caputo, Daniela Cianniello, Michelino De Laurentiis
Cancers
|
April 23, 2022
Male Breast Cancer: From Molecular Genetics to Clinical Management
Matilde Pensabene, Claudia Von Arx, Michelino De Laurentiis
Oncology and Therapy
|
May 31, 2021
How to Optimise Extended Adjuvant Treatment with Neratinib for Patients with Early HER2+ Breast Cancer
Michael Untch, Miguel Martin, Michelino De Laurentiis, et al.
Frontiers in Oncology
|
August 21, 2023
Long-term complete response with third-line PARP inhibitor after immunotherapy in a patient with triple-negative breast cancer: a case report
Roberta Caputo, Martina Pagliuca, Matilde Pensabene, et al.
Frontiers in Oncology
|
February 9, 2026
Direct pulmonary delivery route in lung cancer: a highway for siRNA therapeutics
Muhammad Shakeeb Sharif, Luca Luzzi, Michelino De Laurentiis, et al.
Cancers
|
May 14, 2020
Long Non-Coding RNA <i>HOTAIR</i> in Breast Cancer Therapy
Monica Cantile, Maurizio Di Bonito, Margherita Cerrone, et al.
Oncotarget
|
April 14, 2017
A meta-analytic review of the relationship of cancer coping self-efficacy with distress and quality of life
Andrea Chirico, Fabio Lucidi, Thomas Merluzzi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 5, 2022
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement
Vincenzo Adamo, Lorenzo Antonuzzo, Marco Danova, et al.
Page
of 19